Es gab 50 kürzliche Insider-Transaktionen für Emergent BioSolutions Inc. (EBS), darunter 18 Käufe und 29 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $6.13M und die gesamten Insider-Verkäufe auf $2.1M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Williams Paul Anthony, Lindahl Richard S, Papa Joseph C. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — EBS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-01 |
Williams Paul Anthony |
SVP, Products Business |
Informierter Verkauf |
4,000 |
$8.44 |
$33.76K |
62,681 |
| 2026-03-05 |
Lindahl Richard S |
EVP, Chief Financial Officer |
RSU-Steuereinbehalt |
23,650 |
$8.44 |
$199.61K |
215,367 |
| 2026-03-05 |
Papa Joseph C |
President and CEO |
RSU-Steuereinbehalt |
37,055 |
$8.44 |
$312.74K |
305,445 |
| 2026-03-05 |
Glessner Coleen |
EVP, Quality & Ethics, and Cpl |
RSU-Steuereinbehalt |
8,199 |
$8.44 |
$69.2K |
104,108 |
| 2026-03-05 |
Williams Paul Anthony |
SVP, Products Business |
RSU-Steuereinbehalt |
9,397 |
$8.44 |
$79.31K |
66,681 |
| 2026-03-05 |
Hartzel William |
SVP, Bioservices |
RSU-Steuereinbehalt |
9,493 |
$8.44 |
$80.12K |
87,188 |
| 2026-03-05 |
Perl Jessica |
SVP, General Counsel, Corp Sec |
RSU-Steuereinbehalt |
6,465 |
$8.44 |
$54.56K |
61,004 |
| 2026-03-05 |
Lowry Simon C |
SVP, R&d, CMO |
RSU-Steuereinbehalt |
10,636 |
$8.44 |
$89.77K |
77,803 |
| 2026-03-03 |
Fowler John D Jr |
Director |
RSU-Zuteilung |
5,006 |
$8.99 |
$45K |
5,006 |
| 2026-03-03 |
Lindahl Richard S |
EVP, Chief Financial Officer |
RSU-Zuteilung |
72,856 |
$8.99 |
$654.98K |
557,346 |
| 2026-03-03 |
Papa Joseph C |
President and CEO |
RSU-Zuteilung |
252,194 |
$8.99 |
$2.27M |
1,784,694 |
| 2026-03-03 |
Glessner Coleen |
EVP, Quality & Ethics, and Cpl |
RSU-Zuteilung |
44,834 |
$8.99 |
$403.06K |
294,447 |
| 2026-03-03 |
Williams Paul Anthony |
SVP, Products Business |
RSU-Zuteilung |
44,834 |
$8.99 |
$403.06K |
254,948 |
| 2026-03-03 |
Hartzel William |
SVP, Bioservices |
RSU-Zuteilung |
44,834 |
$8.99 |
$403.06K |
259,545 |
| 2026-03-03 |
Perl Jessica |
SVP, General Counsel, Corp Sec |
RSU-Zuteilung |
46,702 |
$8.99 |
$419.85K |
142,647 |
| 2026-03-03 |
Lowry Simon C |
SVP, R&d, CMO |
RSU-Zuteilung |
44,834 |
$8.99 |
$403.06K |
147,833 |
| 2026-03-01 |
Lindahl Richard S |
EVP, Chief Financial Officer |
RSU-Steuereinbehalt |
683 |
$8.15 |
$5.57K |
239,017 |
| 2026-03-01 |
Fowler John D Jr |
Director |
Unbekannt |
- |
- |
- |
- |
| 2026-02-25 |
Lindahl Richard S |
EVP, Chief Financial Officer |
Option verfallen |
20,321 |
$61.01 |
$1.24M |
- |
| 2026-02-09 |
Perl Jessica |
SVP, General Counsel, Corp Sec |
RSU-Steuereinbehalt |
918 |
$11.03 |
$10.13K |
67,469 |
| 2026-02-06 |
Lindahl Richard S |
EVP, Chief Financial Officer |
RSU-Steuereinbehalt |
5,642 |
$10.92 |
$61.61K |
239,700 |
| 2026-02-06 |
Glessner Coleen |
EVP, Quality & Ethics, and Cpl |
RSU-Steuereinbehalt |
2,852 |
$10.92 |
$31.14K |
112,620 |
| 2026-02-06 |
Williams Paul Anthony |
SVP, Products Business |
RSU-Steuereinbehalt |
1,022 |
$10.92 |
$11.16K |
76,194 |
| 2026-02-06 |
Hartzel William |
SVP, Bioservices |
RSU-Steuereinbehalt |
630 |
$10.92 |
$6.88K |
96,681 |
| 2025-12-14 |
Lowry Simon C |
SVP, R&d, CMO |
RSU-Steuereinbehalt |
3,543 |
$11.41 |
$40.43K |
88,439 |
| 2025-12-05 |
Richard Ronald |
Director |
Optionsausübung (Verkauf) |
25,748 |
$5.02 |
$129.25K |
- |
| 2025-11-11 |
Hartzel William |
SVP, Bioservices |
RSU-Steuereinbehalt |
610 |
$10.88 |
$6.64K |
103,082 |
| 2025-11-10 |
Degolyer Donald W |
Director |
Informierter Verkauf |
17,801 |
$10.54 |
$187.62K |
119,858 |
| 2025-11-07 |
Dayal Sujata Tyagi |
Director |
Informierter Verkauf |
8,552 |
$10.00 |
$85.52K |
88,980 |
| 2025-10-15 |
Lindahl Richard S |
EVP, Chief Financial Officer |
RSU-Steuereinbehalt |
4,995 |
$9.60 |
$47.95K |
291,497 |
| 2025-10-07 |
Glessner Coleen |
EVP, Quality & Ethics, and Cpl |
Informierter Verkauf |
30,608 |
$10.00 |
$306.08K |
144,319 |
| 2025-08-15 |
Zoon Kathryn C |
Director |
Informierter Verkauf |
7,086 |
$8.87 |
$62.85K |
71,799 |
| 2025-08-12 |
Degolyer Donald W |
Director |
Informierter Verkauf |
7,844 |
$8.65 |
$67.83K |
137,659 |
| 2025-07-11 |
Hartzel William |
SVP, Bioservices |
RSU-Steuereinbehalt |
4,263 |
$7.36 |
$31.38K |
103,692 |
| 2025-06-08 |
Lindahl Richard S |
EVP, Chief Financial Officer |
RSU-Steuereinbehalt |
2,733 |
$6.63 |
$18.12K |
296,492 |
| 2025-06-08 |
Glessner Coleen |
EVP, Quality & Ethics, and Cpl |
RSU-Steuereinbehalt |
1,249 |
$6.63 |
$8.28K |
174,927 |
| 2025-06-08 |
Williams Paul Anthony |
SVP, Products Business |
RSU-Steuereinbehalt |
464 |
$6.63 |
$3.08K |
85,871 |
| 2025-06-08 |
Hartzel William |
SVP, Bioservices |
RSU-Steuereinbehalt |
1,167 |
$6.63 |
$7.74K |
107,955 |
| 2025-05-23 |
Katkin Keith |
Director |
Informierter Verkauf |
7,844 |
$6.30 |
$49.42K |
86,431 |
| 2025-05-13 |
Papa Joseph C |
President and CEO |
Informierter Kauf |
60,000 |
$5.83 |
$349.8K |
342,500 |
| 2025-05-07 |
Lindahl Richard S |
EVP, Chief Financial Officer |
Option verfallen |
19,963 |
$48.33 |
$964.81K |
- |
| 2025-04-30 |
Sullivan Louis W |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Katkin Keith |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Richard Ronald |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Harsanyi Zsolt |
Chairman |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
White Marvin L |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Fowler Neal Franklin |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Dayal Sujata Tyagi |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Degolyer Donald W |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
| 2025-04-30 |
Zoon Kathryn C |
Director |
RSU-Zuteilung |
15,824 |
$5.45 |
$86.24K |
41,572 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
